Recombinant Human VEGFR2/Flk-1/KDR Protein (Fc Tag)
PKSH031931
| Size: | Price: | $940 | |
| Qty: |
-
+
|
Lead Time: 7~10 days
Product Details
| Catalog number | PKSH031931 |
| Expression_host | HEK293 Cells |
| Sequence | Met 1-Glu 764 |
| Bio_Activity | 1. Immobilized recombinant human VEGFA at 1. 25 μg/ml (100 μl/well) can bind VEGFR2 with a linear range of 1.25-40.0 ng/ml. 2. Measured by its ability to inhibit the VEGF-dependent proliferation of human umbilical vein endothelial cells (HUVEC). The ED50 for this effect is typically 20-120 ng/mL in the presence of 10 ng/mL recombinant human VEGF165. |
| Application | Functional ELISA |
| Accession | NP_002244.1 |
| Synonyms | Vascular endothelial growth factor receptor 2;KDR;VEGFR-2;Fetal liver kinase 1;FLK-1;Kinase insert domain receptor;Protein-tyrosine kinase receptor flk-1;CD309;Flk-1;FLK1;VEGFR;VEGFR2 |
| Tag | C-hFc |
| Purity | > 90 % as determined by reducing SDS-PAGE. |
| Endotoxin | < 1.0 EU per μg of the protein as determined by the LAL method. |
| Formulation | Lyophilized from sterile PBS, pH 7.4 Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual. |
